BYOMASS
DEAD

Serial Number

90764066

Owner

BYOMass, Inc.

Attorney

Sara M. Bauer

Filing Date

Jun 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BYOMASS Trademark

Serial Number: 90764066

BYOMASS is a trademark filed by BYOMass, Inc. on June 9, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BYOMass, Inc. (2 trademarks)

161 Pantry Road
Sudbury, MA 01776

Entity Type: 03

Trademark Details

Filing Date

June 9, 2021

Registration Date

Not Registered

Published for Opposition

April 5, 2022

Goods & Services

Scientific research and development; providing information about medical and scientific research via a website

Pharmaceutical preparations for use in the treatment, alleviation, and prevention of nausea, appetite loss, weight loss, muscle wasting, fatigue, vomiting, and headaches; pharmaceutical preparations for use in the treatment of weight gain and obesity; pharmaceutical preparations for use in supportive care; pharmaceutical preparations for the treatment, alleviation and prevention of diseases, disorders, and degenerative conditions associated with aging; pharmaceutical preparations for the treatment, alleviation and prevention of chronic diseases, conditions and functional disorders; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment, alleviation and prevention of cancer, tumors, inflammatory diseases, immunological diseases, metabolic diseases, motility disorders, gastrointestinal disorders, musculoskeletal diseases, cardiovascular diseases, respiratory diseases, kidney diseases, neurological and central nervous system disorders, blood disorders, fibrotic diseases, and treatment related toxicities for all the aforementioned diseases and disorders; biologicals and small molecules both in the nature of pharmaceutical preparations for the treatment, alleviation and prevention of transforming growth factor beta (TGF- ß) super family-caused diseases

Providing information and news via a website regarding health and wellness in the field of pharmaceuticals; providing a website that provides medical information on patient support, therapeutic areas and pharmaceutical products

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 16, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 15, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 15, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 15, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 31, 2024 EXRA
SOU EXTENSION 4 GRANTED
May 30, 2024 EX4G
SOU EXTENSION 4 FILED
May 30, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
May 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2023 EXRA
SOU EXTENSION 3 GRANTED
Nov 21, 2023 EX3G
SOU EXTENSION 3 FILED
Nov 21, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2023 EXRA
SOU EXTENSION 2 GRANTED
May 31, 2023 EX2G
SOU EXTENSION 2 FILED
May 31, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
May 31, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 10, 2022 EXRA
SOU EXTENSION 1 GRANTED
Nov 8, 2022 EX1G
SOU EXTENSION 1 FILED
Nov 8, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 8, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 31, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 5, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 1, 2022 XAEC
ASSIGNED TO LIE
Mar 1, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 1, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 1, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2022 CNEA
ASSIGNED TO EXAMINER
Feb 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2021 NWOS
NEW APPLICATION ENTERED
Jun 12, 2021 NWAP